Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

16.47
BATS BZX Real-Time Price
As of 3:00pm ET
 +0.28 / +1.73%
Today’s Change
10.26
Today|||52-Week Range
37.45
-41.88%
Year-to-Date
Why Relypsa (RYLP) Stock Is Surging Today
May 23 / TheStreet.com - Paid Partner Content
2 Promising Biopharmas Reach Key Junctures
May 23 / TheStreet.com - Paid Partner Content
Why Relypsa Inc. Is Moving Higher Today
May 23 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: You Don't Want to Touch UBS
May 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close16.19
Today’s open16.44
Day’s range15.92 - 16.57
Volume82,521
Average volume (3 months)2,413,905
Market cap$724.5M
Dividend yield--
Data as of 3:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-80.66%
Earnings growth (this year)-34.88%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales62.18
Price/Book3.68

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...-0.28-2.73%
CHRSCoherus BioSciences ...+0.03+0.16%
MNTAMomenta Pharmaceutic...-0.12-1.08%
FMIFoundation Medicine ...-0.22-1.18%
Data as of 3:00pm ET, 05/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.49
Annual revenue (last year)$18.6M
Annual profit (last year)-$178.7M
Net profit margin-963.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Chief Financial Officer &
Senior Vice President
Kristine McClintock Ball
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs